These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 18765384

  • 1. Letter by De Backer et al regarding article, "Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study".
    De Backer TL, Vander Stichele RH, Van Bortel LM.
    Circulation; 2008 Sep 02; 118(10):e151. PubMed ID: 18765384
    [No Abstract] [Full Text] [Related]

  • 2. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
    Limbs International Medicinal Buflomedil (LIMB) Study Group, Leizorovicz A, Becker F.
    Circulation; 2008 Feb 12; 117(6):816-22. PubMed ID: 18212283
    [Abstract] [Full Text] [Related]

  • 3. Buflomedil in peripheral arterial disease: trials and tribulations.
    Conte MS.
    Circulation; 2008 Feb 12; 117(6):717-9. PubMed ID: 18268159
    [No Abstract] [Full Text] [Related]

  • 4. Double-blind placebo-controlled trial of buflomedil in intermittent claudication.
    Fonseca V, Mikhailidis DP, Barradas MA, Jeremy JY, Gracey L, Dandona P.
    Int J Clin Pharmacol Res; 1988 Feb 12; 8(5):377-81. PubMed ID: 3229875
    [Abstract] [Full Text] [Related]

  • 5. Anti-platelet therapy: is it all over in peripheral artery disease?
    Jaipersad AS, Silverman SH, Lip GY.
    Thromb Haemost; 2010 Apr 12; 103(4):689-91. PubMed ID: 20174749
    [No Abstract] [Full Text] [Related]

  • 6. A randomized trial of iloprost in patients with intermittent claudication.
    Creager MA, Pande RL, Hiatt WR.
    Vasc Med; 2008 Feb 12; 13(1):5-13. PubMed ID: 18372433
    [Abstract] [Full Text] [Related]

  • 7. Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (PROVIDENCE-1).
    Jaff MR, Dale RA, Creager MA, Lipicky RJ, Constant J, Campbell LA, Hiatt WR.
    Circulation; 2009 Jan 27; 119(3):452-8. PubMed ID: 19139383
    [Abstract] [Full Text] [Related]

  • 8. [Buflomedil in arterial occlusive disease. Results of a controlled study].
    Trübestein G, Balzer K, Bisler H, Klüken N, Mahfoud Y, Müller-Wiefel H, Unkel B, Ziegler W.
    Dtsch Med Wochenschr; 1982 Dec 24; 107(51-52):1957-61. PubMed ID: 6756854
    [No Abstract] [Full Text] [Related]

  • 9. Is it possible to reduce the risk of cardiovascular events in subjects suffering from intermittent claudication of the lower limbs?
    Boissel JP, Peyrieux JC, Destors JM.
    Thromb Haemost; 1989 Sep 29; 62(2):681-5. PubMed ID: 2683189
    [Abstract] [Full Text] [Related]

  • 10. Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication.
    Diamantopoulos EJ, Grigoriadou M, Ifanti G, Raptis SA.
    Int Angiol; 2001 Dec 29; 20(4):337-44. PubMed ID: 11782701
    [Abstract] [Full Text] [Related]

  • 11. Double-blind placebo-controlled trial of buflomedil in the treatment of Raynaud's phenomenon: six-month follow-up.
    Le Quentrec P, Lefebvre ML.
    Angiology; 1991 Apr 29; 42(4):289-95. PubMed ID: 1673051
    [Abstract] [Full Text] [Related]

  • 12. [Epidemiologic study of peripheral obstructive arteriopathies: clinical effects of treatment with buflomedil chlorhydrate (Loftyl). Processing of data furnished by a polycenter study].
    Minerva Med; 1985 Oct 13; 76(39):1803-11. PubMed ID: 4047463
    [Abstract] [Full Text] [Related]

  • 13. [Effect of buflomedil perfusion on peripheral tissue oxygenation during transluminal angioplasty in patients with advanced arteriopathy of the lower limbs].
    Joffre F, Meites G, Rousseau H, Staffin C, Allaert FA, Pelat P.
    Ann Radiol (Paris); 1994 Oct 13; 37(3):239-44. PubMed ID: 8092756
    [Abstract] [Full Text] [Related]

  • 14. Control of hypertension in patients with peripheral artery disease.
    Clement DL.
    Blood Press; 2006 Oct 13; 15(4):251-2. PubMed ID: 17078187
    [No Abstract] [Full Text] [Related]

  • 15. Buflomedil in arterial occlusive disease: results of a controlled multicenter study.
    Trübestein G, Balzer K, Bisler H, Klüken N, Muller-Wiefel H, Unkel B, Mahfoud Y, Ziegler W.
    Angiology; 1984 Aug 13; 35(8):500-5. PubMed ID: 6383127
    [Abstract] [Full Text] [Related]

  • 16. Beta blockers for peripheral arterial disease.
    Paravastu SC, Mendonca DA, da Silva A.
    Eur J Vasc Endovasc Surg; 2009 Jul 13; 38(1):66-70. PubMed ID: 19359199
    [Abstract] [Full Text] [Related]

  • 17. Warning! One buflomedil may hide another one!
    Chiffoleau A, Yatim D, Garrec F, Veyrac G, Raoult P, Larousse C, Bourin M.
    Therapie; 2000 Jul 13; 55(1):221-3. PubMed ID: 10860027
    [Abstract] [Full Text] [Related]

  • 18. Comparison of safety and efficacy of buflomedil and naftidrofuryl in the treatment of intermittent claudication.
    Rosas G, Cerdeyra C, Lucas MA, Parano JR, Villa JJ.
    Angiology; 1981 May 13; 32(5):291-7. PubMed ID: 7235299
    [Abstract] [Full Text] [Related]

  • 19. [Buflomedil in the treatment of chronic peripheral arterial diseases. Case contribution].
    Visconti W, Grillo N.
    Minerva Med; 1985 May 12; 76(19-20):945-53. PubMed ID: 3158842
    [Abstract] [Full Text] [Related]

  • 20. [Clinical study of the effect of buflomedil on peripheral neuropathy in diabetic patients].
    Zhou M, Lei MX.
    Hunan Yi Ke Da Xue Xue Bao; 2001 Jun 28; 26(3):239-40. PubMed ID: 12536693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.